(Q37253723)

19 August 2017

Influence of clinical communication on patients' decision making on participation in clinical trials (English)

1 reference

19 August 2017

0 references

1 reference

9

John C Ruckdeschel

0 references

Susan Eggly

object named as

Susan S Eggly

2

0 references

Felicity W K Harper

4

object named as

Felicity W K Harper

1 reference

19 August 2017

Terrance L Albrecht

1

1 reference

19 August 2017

Marci E J Gleason

3

1 reference

19 August 2017

Tanina S Foster

5

1 reference

19 August 2017

Amy M Peterson

6

1 reference

19 August 2017

Heather Orom

7

1 reference

19 August 2017

Louis A Penner

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Journal of Clinical Oncology

19 August 2017

1 reference

19 August 2017

26

1 reference

19 August 2017

16

1 reference

19 August 2017

2666-2673

1 reference

Oncologists' recommendations of clinical trial participation to patients

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Provider roles in the recruitment of underrepresented populations to cancer clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

The physician-patient working alliance.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Factors influencing inclusion of patients with malignancies in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

A portable, unobtrusive device for videorecording clinical interactions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Communication and informed consent

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Patient-physician communication concerning participation in cancer chemotherapy trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Communication and consumer decision making about cancer clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Information seeking during "bad news" oncology interactions: Question asking by patients and their companions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Patients' decision-making process regarding participation in phase I oncology research.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Predictors of enrollment in lung cancer clinical trials

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Managing accrual in cooperative group clinical trials.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Seeking informed consent to cancer clinical trials: describing current practice.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Understanding patient decisions about clinical trials and the associated communication process: a preliminary report

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Clinicians' attitudes to clinical trials of cancer therapy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials

3 September 2018

1 reference

12 December 2020

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

12 December 2020

Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision

1 reference

12 December 2020

Information and decision-making preferences of hospitalized adult cancer patients

1 reference

12 December 2020

Strategic physician communication and oncology clinical trials

1 reference

12 December 2020

Participation in the RACS sentinel node biopsy versus axillary clearance trial

1 reference

12 December 2020

Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001

1 reference

12 December 2020

Altruism as a reason for participation in clinical trials was independently associated with adherence

1 reference

12 December 2020

Physician Perspectives on Cancer Clinical Trials and Barriers to Minority Recruitment

1 reference

12 December 2020

Factors associated with participation in breast cancer treatment clinical trials

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2007.14.8114

1 reference

19 August 2017

1 reference

19 August 2017

1 reference